Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Allterum Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Allterum Therapeutics

Allterum Therapeutics

Biopharmaceutical firm, Allterum Therapeutics, innovates immunotherapies for various IL-7R expressing cancers.

HQ
Houston, TX, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Allterum Therapeutics is a biopharmaceutical company focused on developing innovative immunotherapies for cancers expressing the IL-7 receptor (IL-7R). The company's primary product is a monoclonal antibody targeting CD127 (IL-7Rα), aimed at treating relapsed acute lymphoblastic leukemia and other IL-7R over-expressing cancers, including refractory solid tumors. Founded by Fannin Innovation Studio in Houston, TX, Allterum leverages cutting-edge research from the National Cancer Institute.

Allterum Therapeutics has made significant strides in oncology, particularly with its exclusive license of the 4A10 antibody from the National Cancer Institute. This antibody shows promise in targeting IL-7R expressing cancers, positioning Allterum as a leader in this niche market. The company's work has the potential to significantly impact cancer treatment, offering new hope for patients with difficult-to-treat malignancies.

Allterum Therapeutics - Similar Companies

Aleta Biotherapeutics logo

Aleta Biotherapeutics

aletabio.com

Alterome Therapeutics logo

Alterome Therapeutics

alterome.com

Allogene Therapeutics logo

Allogene Therapeutics

allogene.com

LTZ Therapeutics logo

LTZ Therapeutics

AltruBio logo

AltruBio

Cellerant Therapeutics logo

Cellerant Therapeutics

Tallac Therapeutics logo

Tallac Therapeutics

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

ALX Oncology Holdings logo

ALX Oncology Holdings

alxoncology.com

Alltrna logo

Alltrna

alltrna.com

Palm Therapeutics logo

Palm Therapeutics

Allorion Therapeutics logo

Allorion Therapeutics

alloriontx.com

Alloplex Biotherapeutics logo

Alloplex Biotherapeutics

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Asher Bio logo

Asher Bio

asherbio.com

Allterum Therapeutics - Quick Facts

Who are Allterum Therapeutics' competitors?

Companies similar to Allterum Therapeutics include Aleta Biotherapeutics, Alterome Therapeutics, Allogene Therapeutics and LTZ Therapeutics.

When was Allterum Therapeutics founded?

Allterum Therapeutics was founded in 2018.

Where is Allterum Therapeutics' headquarters located?

Allterum Therapeutics' headquarters is located in Houston, TX, US.

When was Allterum Therapeutics' last funding round?

Allterum Therapeutics' most recent funding round was for $1.8M (USD) in December 2020.

How much has Allterum Therapeutics raised to-date?

As of Dec 17, 2020, Allterum Therapeutics has raised a total of $4.7M (USD).

How many employees does Allterum Therapeutics have?

Allterum Therapeutics has 6 employees as of Feb 4, 2024.

Allterum Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Immunotherapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research